| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |